Qol At 3 Years After Diagnosis In Aggressive Lymphoma Survivors.

9586 Background: Patients with aggressive lymphoma are potentially curable, but longer-term effects of treatment may adversely impact quality of life (QOL). We examined QOL scores at baseline enrollment and 3 year follow-up in survivors of aggressive lymphoma. Methods: Newly diagnosed lymphoma patients were prospectively enrolled within 9 months of diagnosis in the University of Iowa/Mayo Clinic SPORE Molecular Epidemiology Resource (MER) and systematically followed. We measured baseline QOL at time of enrollment and at 3 years after diagnosis with the Functional Assessment of Cancer Therapy-General (FACT-G) scale. This scale measures well-being (WB) in 4 QOL domains—physical (PWB), social/family (SWB), emotional (EWB), functional (FWB)—along with a total FACT-G score (TOT). For this study, we defined “survivor” as alive at 3 year follow-up with no active disease or treatment within the previous year. Results: From 2002-2009, 1902 patients with aggressive lymphoma were prospectively enrolled. Of these, 47...